Leiderman Elisabeth's Form 4 filing
bluebird bio, Inc. (BLUE) · filed Mar 9, 2023
- Accession no.
- 0001562180-23-002662
- Filed
- Mar 9, 2023
- Trade date
- Oct 17, 2022
- Filing delay
- 143 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $6.49K. It was filed 143 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leiderman ElisabethCIK 0001842133 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 17, 2022 | Common Stock | SSaleDisposed | −1,004 | $6.46F2 | −$6,485.84 | 11,466 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The range in prices for the transaction reported on this line was $6.4614 to $6.4671. The average weighted price was $6.4643. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
Remarks
Due to an administrative oversight, shares were inadvertently sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units on behalf of the Reporting Person, a non-employee director.